Laxmi Organic Industries Reports Zero Deviation in IPO Proceeds Utilization for Q3FY26

2 min read     Updated on 29 Jan 2026, 10:24 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Laxmi Organic Industries Limited reported zero deviation in IPO proceeds utilization for Q3FY26, with Axis Bank's monitoring report confirming 0% deviation from March 2021 prospectus objects. The company has utilized ₹4,754.72 million out of ₹5,000.00 million raised, with ₹245.27 million remaining unutilized and deployed in fixed deposits. Major allocations included ₹1,729.25 million for debt repayment and ₹910.63 million for facility expansion, demonstrating strong governance and regulatory compliance.

31251273

*this image is generated using AI for illustrative purposes only.

Laxmi Organic Industries Limited has successfully maintained complete compliance with its IPO proceeds utilization plan, reporting zero deviation for the quarter ended December 31, 2025. The chemical industry company filed its monitoring agency report under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming adherence to all objects stated in its March 18, 2021 prospectus.

Monitoring Agency Confirms Zero Deviation

Axis Bank Limited, serving as the monitoring agent, issued a comprehensive report validating the company's IPO proceeds deployment. The monitoring agency confirmed no deviation from the original objects and reported a 0% deviation range across all categories.

Parameter Status Details
Deviation from Objects No Deviation All utilization as per offer document
Range of Deviation 0% No percentage deviation observed
Shareholder Approval Required Not Applicable No material deviations occurred
Government Approvals Yes All statutory approvals obtained

IPO Proceeds Structure and Utilization

The company's March 2021 IPO raised ₹5,000.00 million through fresh issue, with net proceeds of ₹4,843.78 million after deducting offer expenses of ₹156.22 million. The original offer expenses estimate showed savings of ₹43.58 million, which was allocated to general corporate purposes.

Utilization Category Original Amount (₹ Million) Amount Utilized (₹ Million) Unutilized Balance (₹ Million)
Investment in YFCPL for Capex 604.04 604.04 -
Investment in YFCPL for Working Capital 377.41 132.13 245.27
SI Manufacturing Facility Expansion 910.63 910.63 -
Company Working Capital Requirements 351.78 351.78 -
Plant and Machinery Purchase 125.65 125.65 -
Debt Repayment 1,729.25 1,729.25 -
General Corporate Purposes 745.02 745.02 -
Offer Related Expenses 156.22 156.22 -
Total 5,000.00 4,754.72 245.27

Strategic Deployment Across Multiple Objects

The proceeds utilization spans eight key areas, with significant allocations toward debt repayment (₹1,729.25 million) and facility expansion (₹910.63 million). The company has completed utilization for most objects, with only the YFCPL working capital investment showing partial deployment.

Key facility locations include:

  • Lote, Maharashtra: YFCPL capital expenditure and working capital projects
  • Mahad, Maharashtra: SI Manufacturing Facility expansion and infrastructure development

Unutilized Funds Management

The remaining ₹245.27 million in unutilized proceeds has been prudently deployed in fixed deposits to ensure capital preservation while generating returns.

Investment Type Amount (₹ Million) Maturity Date ROI (%) Market Value (₹ Million)
Fixed Deposit - Axis Bank 87.50 January 10, 2026 6.05% 90.04
Fixed Deposit - HDFC 157.70 March 16, 2026 4.75% 158.08
Total 245.20 - - 248.12

Compliance and Governance Excellence

The monitoring report highlights the company's strong governance framework, with all certifications provided by chartered accountants and no unfavorable events affecting object viability. The company has obtained all necessary government and statutory approvals for its projects, demonstrating comprehensive regulatory compliance.

This zero-deviation report reinforces Laxmi Organic Industries' commitment to transparent capital deployment and adherence to investor commitments made during its public offering. The systematic utilization of IPO proceeds across strategic growth initiatives positions the company well for its expansion objectives in the chemical industry.

Historical Stock Returns for Laxmi Organic Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-0.93%-17.89%-48.22%-31.60%-29.71%
Laxmi Organic Industries
View Company Insights
View All News
like19
dislike

Laxmi Organic Industries Schedules Q3FY26 Earnings Conference Call for January 30, 2026

1 min read     Updated on 20 Jan 2026, 02:56 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Laxmi Organic Industries Limited has scheduled its Q3FY26 earnings conference call for January 30, 2026, at 2:00 PM IST to discuss operational and financial performance for the quarter and nine months ended December 31, 2025. The call will be led by MD & CEO Dr. Rajan Venkatesh and CFO Mr. Mahadeo Karnik, with comprehensive dial-in access provided including toll-free numbers for international participants from USA, UK, Singapore, and Hong Kong.

30446786

*this image is generated using AI for illustrative purposes only.

Laxmi Organic Industries Limited has announced its earnings conference call to discuss the operational and financial performance for the third quarter of fiscal year 2026. The company issued a formal intimation to stock exchanges on January 20, 2026, regarding the scheduled investor and analyst meet.

Conference Call Details

The earnings conference call is scheduled for Friday, January 30, 2026, at 2:00 PM IST (14:00 hours). The call will focus on discussing financial results for the quarter and nine months ended December 31, 2025. This announcement was made pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Date: Friday, January 30, 2026
Time: 2:00 PM IST
Period Covered: Q3FY26 and nine months ended December 31, 2025
Format: Earnings Conference Call

Access Information

The company has provided comprehensive dial-in details for participants to join the earnings call. Multiple access options are available to accommodate both domestic and international participants.

Access Type: Contact Details
Primary Numbers: +91 22 6280 1309 / +91 22 7115 8210
USA Toll Free: 1 866 746 2133
UK Toll Free: 0808 101 1573
Singapore Toll Free: 800 101 2045
Hong Kong Toll Free: 800 964 448

Key Participants

The earnings conference call will be led by senior management representatives who will present the company's performance and address participant queries:

  • Dr. Rajan Venkatesh – Managing Director & Chief Executive Officer
  • Mr. Mahadeo Karnik – Chief Financial Officer

Registration and Contact Information

Participants are encouraged to pre-register for the call through the registration link provided by the company. For additional queries and RSVP, participants can contact the designated representatives from Strategic Growth Advisors Pvt. Ltd.:

  • Mr. Sagar Shroff: +91 98205 19303
  • Mr. Tanay Shah: +91 98333 91899

The company secretary and compliance officer, Aniket Hirpara, signed the official communication digitally on January 20, 2026, ensuring compliance with regulatory requirements for investor communication.

Historical Stock Returns for Laxmi Organic Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-0.93%-17.89%-48.22%-31.60%-29.71%
Laxmi Organic Industries
View Company Insights
View All News
like19
dislike

More News on Laxmi Organic Industries

1 Year Returns:-31.60%